Plexxikon Inc. v. Novartis Pharmaceuticals Corporation

Filing 160

ORDER by Judge Haywood S. Gilliam, Jr. Granting 159 Stipulation to Permit Deposition of Malackowski After the Expert Discovery Cutoff Date. (ndrS, COURT STAFF) (Filed on 5/1/2019)

Download PDF
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 DURIE TANGRI LLP DARALYN J. DURIE (SBN 169825) ddurie@durietangri.com LAURA E. MILLER (SBN 271713) lmiller@durietangri.com RAGHAV R. KRISHNAPRIYAN (SBN 273411) rkrishnapriyan@durietangri.com MATTHEW W. SAMUELS (SBN 294668) msamuels@durietangri.com 217 Leidesdorff Street San Francisco, CA 94111 Telephone: 415-362-6666 Facsimile: 415-236-6300 YOUNG BASILE HANLON & MACFARLANE, P.C. JEFFREY D. WILSON (Pro Hac Vice) wilson@youngbasile.com ANDREW R. BASILE, JR. (SBN 208396) abasile@youngbasile.com EDDIE D. WOODWORTH (Pro Hac Vice) woodworth@youngbasile.com RYAN T. MCCLEARY (Pro Hac Vice) mccleary@youngbasile.com 3001 W. Big Beaver Road, Suite 624 Troy, MI 48084 Telephone: (248) 649-3333 Facsimile: (248) 649-3338 Attorneys for Plaintiff PLEXXIKON INC. MCDERMOTT WILL & EMERY LLP Thomas P. Steindler (Pro Hac Vice) tsteindler@mwe.com Paul M. Schoenhard (Pro Hac Vice submitted) pschoenhard@mwe.com Ian B. Brooks (Pro Hac Vice) ibrooks@mwe.com David Mlaver (Pro Hac Vice) dmlaver@mwe.com 500 N. Capitol St, NW Washington, DC 20001 Telephone: 202-756-8000 MCDERMOTT WILL & EMERY LLP William G. Gaede, III (SBN 136184) wgaede@mwe.com 275 Middlefield Road, Suite 100 Menlo Park, CA 94025 Telephone: 650-815-7400 Facsimile: 650-815-7401 MCDERMOTT WILL & EMERY LLP K. Nicole Clouse (Pro Hac Vice) nclouse@mwe.com 28 State Street Boston, MA 02109 Telephone: 617-535-3841 Attorneys for Defendant NOVARTIS PHARMACEUTICALS CORPORATION 17 IN THE UNITED STATES DISTRICT COURT 18 FOR THE NORTHERN DISTRICT OF CALIFORNIA 19 OAKLAND DIVISION 20 PLEXXIKON INC., 21 22 23 24 25 Case No. 4:17-cv-04405-HSG Plaintiff, v. NOVARTIS PHARMACEUTICALS CORPORATION, STIPULATION AND [PROPOSED] ORDER TO PERMIT DEPOSITION OF MALACKOWSKI AFTER THE EXPERT DISCOVERY CUTOFF DATE Ctrm: 2 – 4th Floor Judge: Honorable Haywood S. Gilliam, Jr. Defendant. 26 27 28 STIPULATION AND [PROPOSED] ORDER TO PERMIT MALACKOWSKI DEPOSITION AFTER THE EXPERT DISCOVERY CUTOFF DATE / CASE NO. 4:17-CV-04405-HSG 1 Pursuant to Northern District of California Civil Local Rules 6-2 and 7-12, Plaintiff Plexxikon 2 Inc. (“Plexxikon”) and Defendant Novartis Pharmaceuticals Corporation (“NPC”) stipulate and request 3 that the Court enter an order permitting the deposition of James E. Malackowski to occur on May 4, 2019 4 after the May 2, 2019 close of expert discovery. Specifically, the parties have arranged to complete all 5 other expert depositions within the expert discovery period. The earliest available mutually agreeable 6 time for Mr. Malackowski, one of NPC’s experts, to be deposed is May 4, 2019. Accordingly, the parties 7 seek to extend expert discovery for the limited purpose of allowing the parties to complete the deposition 8 of Mr. Malackowski. 9 On December 22, 2017, the Court issued a scheduling order setting deadlines through claim 10 construction. See ECF No. 57. On June 5, 2018, the parties filed a joint motion to amend the scheduling 11 order and set a schedule for the remainder of the case. See ECF No. 76. The Court issued a revised 12 scheduling order on June 20, 2018, setting, in relevant part, a fact discovery cutoff date of January 17, 13 2019, an expert discovery cutoff date of May 2, 2019, and a trial start date of October 7, 2019. See ECF 14 No. 80. This order explained that “[t]hese dates may only be altered by order of the Court and only upon 15 a showing of good cause.” Id. at 1. On January 11, 2019, the parties filed a stipulation and proposed 16 order seeking to permit the parties to take certain fact depositions on or before February 6, 2019. See 17 ECF No. 117. The Court entered the order on January 14, 2019. See ECF No. 118. There have been no 18 subsequent time modifications in this case, either by stipulation or Court order. 19 Permitting the parties to conduct a single deposition on the aforementioned date will not affect 20 any of the remaining dates set by the Court’s June 20, 2018 Revised Scheduling Order. 1 Moreover, 21 good cause exists to take this deposition after the close of expert discovery. The parties have been 22 working diligently to schedule depositions, but witness and attorney schedules have made it necessary to 23 schedule this deposition after the May 2, 2019 expert discovery cutoff date. Plexxikon reserves its rights 24 to seek discovery arising out of Mr. Malackowski’s deposition, and Novartis agrees not to object to 25 Plexxikon seeking such discovery on the grounds that the deposition took place two days after the 26 discovery cut-off date. 27 28 1 This stipulation does not modify the calculated deadline for submitting dispositive motions, which remains June 3, 2019. 1 STIPULATION AND [PROPOSED] ORDER TO PERMIT MALACKOWSKI DEPOSITION AFTER THE EXPERT DISCOVERY CUTOFF DATE / CASE NO. 4:17-CV-04405-HSG 1 2 Dated: April 30, 2019 3 McDERMOTT WILL & EMERY LLP By: 4 /s/ Thomas P. Steindler THOMAS P. STEINDLER Attorney for Defendant NOVARTIS PHARMACEUTICALS CORPORATION 5 6 7 8 9 DURIE TANGRI LLP Dated: April 30, 2019 10 By: 11 12 /s/ Daralyn J. Durie DARALYN J. DURIE Attorney for Plaintiff PLEXXIKON INC. 13 14 15 FILER’S ATTESTATION 16 17 18 19 Pursuant to Civil L.R. 5-1(i)(3), regarding signatures, I, Thomas P. Steindler, attest that concurrence in the filing of this document has been obtained. Dated: April 30, 2019 /s/ Thomas P. Steindler THOMAS P. STEINDLER 20 21 22 23 24 25 26 27 28 2 STIPULATION AND [PROPOSED] ORDER TO PERMIT MALACKOWSKI DEPOSITION AFTER THE EXPERT DISCOVERY CUTOFF DATE / CASE NO. 4:17-CV-04405-HSG 1 [PROPOSED] ORDER 2 PURSUANT TO STIPULATION, IT IS SO ORDERED. 3 4 5 Dated: 5/1/2019 HON. HAYWOOD S. GILLIAM, JR. UNITED STATES DISTRICT JUDGE 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 3 STIPULATION AND [PROPOSED] ORDER TO PERMIT MALACKOWSKI DEPOSITION AFTER THE EXPERT DISCOVERY CUTOFF DATE / CASE NO. 4:17-CV-04405-HSG

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?